Sansheng Pharmaceutical pre-charged Isep ® the production of new drugs for water needles received by the State Drug Administration

Yesterday (July 29), China's leading bio
pharmaceutical(http://company(http://Sansheng Pharmaceuticals (01530HK) announced that the antibody fusion proteindrug(http://product(http://®) developed by the company's Sansheng Guojian Pharmaceuticals (Shanghai) Co., Ltdhas submitted to the StateDrug(http://Regulatory Authority an application for the production of the new drug (http:// 　　Pre-charged Essep ® hydroneedles (generic name: Recombinant Human Type II tumor necrosis receptor-antibody fusion protein injection) this pre-charged Isep ® water needle is China's first independently developed pre-filled fusion protein injection 　　Pre-filled Essep ® water needles are used in the treatment of three indications, namely active hypertrophic syllritis, moderate and severe active rheumatoid arthritis, moderate and severe plaque psoriasis in adults 18 years of age and over 　　According to the research, the prevalence of these three diseases in China is about 0.3% 1, 0.4%2, 0.1%3 respectively This pre-charged Isep ® water needles in the domestic biologics preparation process (http:// achieved a major breakthrough, so that patients are no longer limited to hospital treatment, but can inject themselves at home, is expected to greatly improve patients' drug compliance, improve the quality of life of patients 　　About Isep ®
Isepop ®, which was launched in 2006 and has so far benefited more than 300,000 patients from treatment, has received professional recognition from clinicians and extensive patient trust, and was included in the National Health Insurance List class B drugs in 2017